Patil et al.
JOCArticle
(300 MHz, CDCl3) δ 6.99-6.95 (m, 2H), 6.71 (t, J = 7.6 Hz,
1H), 6.47 (d, J = 8.3 Hz, 1H), 4.58 (ABq, J = 16.6 Hz, 2H), 3.70
(brs, 1H), 2.02 (ABq, J = 12.8 Hz, 2H), 1.87-1.60 (m, 6H), 1.54
(s, 3H), 1.42-1.23 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 178.4,
141.8, 127.4, 126.8, 118.9, 117.3, 116.1, 69.6, 45.4, 44.7, 38.5,
35.0, 33.5, 26.8, 25.2, 22.2, 22.1; IR (KBr) νmax 3323, 2926, 2849,
1664, 1490, 1251, 1207, 1096, 746 cm-1; HRMS calcd for
C17H23N2O (Mþ þ H) 271.1810, found 271.1816.
IR (KBr) νmax 3341, 2964, 2924, 1678, 1489, 1398, 1228, 1101,
1029, 636 cm-1; HRMS calcd for C14H19N2O (Mþ þ H)
231.1497, found 231.1494.
7-Methoxy-3a-methyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]-
quinazolin-1-one (5j). Brown solid; mp = 104-106 °C; Rf = 0.48
(hexane/EtOAc = 30/70); 1H NMR (300 MHz, CDCl3) δ 6.63-
6.49 (m, 3H), 4.53 (ABq, J = 17.4 Hz, 2H), 3.72 (s, 3H), 3.48
(brs, 1H), 2.58-2.39 (m, 2H), 2.15-1.99 (m, 2H), 1.50 (s,
3H); 13C NMR (75 MHz, CDCl3) δ 174.0, 153.3, 135.2, 118.9,
118.3, 114.1, 111.4, 72.0, 55.6, 38.7, 32.9, 29.5, 25.0; IR (KBr)
4b-Methyl-4b,5,10,12-tetrahydroisoindolo[1,2-b]quinazolin-12-
one (5d). Pale yellow solid; mp =222-224 °C; Rf = 0.32
(hexane/EtOAc = 30/70); 1H NMR (500 MHz, DMSO-d6)
δ 7.80-7.76 (m, 2H), 7.63 (t, J = 6.7 Hz, 1H), 7.52 (t, J = 6.7
Hz, 1H), 7.10 (d, J = 8.1 Hz, 1H), 7.05 (t, J = 8.1 Hz, 1H), 6.77
(t, J = 8.1 Hz, 1H), 6.70 (d, J = 8.1 Hz, 1H), 5.85 (brs, 1H), 4.83
(ABq, J = 17.5 Hz, 2H), 1.70 (s, 3H); 13C NMR (75 MHz,
DMSO-d6) δ 165.1, 147.6, 140.5, 131.4, 130.3, 128.4, 127.0,
126.1, 123.0, 120.7, 118.1, 116.2, 116.0, 70.5, 37.2, 23.0; IR
(KBr) νmax 3291, 2955, 2923, 2864, 1677, 1495, 1393, 1206, 1098,
1016, 841, 744, 694 cm-1; HRMS calcd for C16H15N2O (Mþ þ
H) 251.1184, found 251.1170.
νmax 3307, 2964, 1674, 1504, 1229, 1180, 1034, 834, 665 cm-1
;
HRMS calcd for C13H17N2O2 (Mþ þ H) 233.1290, found
233.1298.
7-Chloro-3a,5-dimethyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]-
quinazolin-1-one (5k). Darkbrownsolid;mp=144-146 °C; Rf =
0.33 (hexane/EtOAc = 30/70); 1H NMR(300 MHz, CDCl3) δ6.89
(s, 1H), 6.87 (s, 1H), 4.42 (ABq, J = 17.2 Hz, 2H), 3.63 (brs, 1H),
2.55-2.42 (m, 2H), 2.18-2.20 (m, 2H), 2.07 (s, 3H), 1.51 (s, 3H);
13C NMR (75 MHz, CDCl3) δ 174.1, 138.5, 128.4, 125.3, 124.1,
123.2, 118.1, 71.9, 38.3, 32.9, 29.4, 25.7, 16.9; IR (KBr) νmax 3336,
2964, 1678, 1482, 1396, 1227, 1169, 865, 723 cm-1; HRMS calcd for
C13H16ClN2O (Mþ þ H) 251.0951, found 251.0968.
3a-Ethyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]quinazolin-1-one
(5e). Brown solid; mp = 148-150 °C; Rf = 0.53 (hexane/EtOAc =
70/30); 1H NMR (300 MHz, CDCl3) δ 7.00-6.95 (m, 2H), 6.72
(t, J = 7.6 Hz, 1H), 6.49 (d, J = 7.6 Hz, 1H), 4.52 (ABq,
J = 16.6 Hz, 2H), 4.05 (brs, 1H), 2.59-2.38 (m, 2H), 2.18-2.08
(m, 1H), 1.94-1.78 (m, 3H), 0.94 (t, J = 7.5 Hz, 3H); 13C NMR
(75 MHz, CDCl3) δ 174.6, 141.6, 127.6, 126.9, 119.1, 117.6,
116.3, 74.7, 38.8, 29.8, 29.5, 29.4, 7.7; IR (KBr) νmax 3290, 2964,
2932, 1679, 1608, 1441, 1160, 983, 746 cm-1; HRMS calcd for
C13H17N2O (Mþ þ H) 217.1340, found 217.1341.
8-Chloro-3a-methyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]qui-
nazolin-1-one (5l). Yellow solid; mp = 128-130 °C; Rf = 0.36
(hexane/EtOAc = 30/70); 1H NMR (300 MHz, CDCl3) δ 6.93
(t, J = 7.7 Hz, 1H), 6.76 (d, J = 7.9 Hz, 1H), 6.39 (d, J = 7.9 Hz,
1H), 4.51 (ABq, J = 17.6 Hz, 2H), 4.00 (brs, 1H), 2.51-2.44 (m,
2H), 2.09-2.04 (m, 2H), 1.53 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 174.4, 143.6, 128.2, 126.9, 119.5, 116.4, 114.5, 71.9,
37.6, 32.6, 29.5, 25.3; IR (KBr) νmax 3292, 2975, 1682, 1395,
1233, 1200, 821, 780 cm-1; HRMS calcd for C12H14ClN2O (Mþ þ
H) 237.0795, found 237.0793.
3a-Octyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]quinazolin-1-one
(5f). Brown solid; mp =98-100 °C; Rf = 0.76 (hexane/EtOAc =
70/30); 1H NMR (500 MHz, CDCl3) δ 6.99-6.95(m, 2H), 6.71 (t,
J = 7.8 Hz, 1H), 6.47 (d, J = 7.8 Hz, 1H), 4.51 (ABq, J = 16.6
Hz, 2H), 2.53-2.39 (m, 2H), 2.15-2.01 (m, 1H), 1.92-1.80 (m,
1H), 1.80-1.69 (m, 2H), 1.35-1.23 (m, 12H), 0.86 (t, J = 6.8 Hz,
3H); 13C NMR (75 MHz, CDCl3) δ 174.5, 141.6, 127.5, 126.8,
119.0, 117.4, 116.1, 74.3, 38.7, 37.2, 31.7, 29.9, 29.5, 29.4, 29.1,
23.4, 22.5, 14.0; IR (KBr) νmax 3307, 2926, 2854, 1673, 1449, 1260,
1198, 813, 745 cm-1; HRMS calcd for C19H29N2O (Mþ þ H)
301.2280, found 301.2287.
8-Fluoro-3a-methyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]quina-
zolin-1-one (5m). Pale yellow solid; mp = 140-142 °C; Rf =
0.36 (hexane/EtOAc = 30/70); H NMR (300 MHz, CDCl3)
1
δ 6.95 (dd, J = 8.2, 6.4 Hz, 1H), 6.44 (t, J = 8.3 Hz, 1H), 6.27 (d,
J = 8.1 Hz, 1H), 4.57 (ABq, J = 17.4 Hz, 2H), 4.05 (brs, 1H),
2.58-2.40 (m, 2H), 2.12-2.02 (m, 2H), 1.50 (s, 3H); 13C NMR
(75 MHz, CDCl3) δ 174.4, 161.8, 158.6, 143.5, 131.9, 128.3,
128.2, 111.3, 105.2, 104.9, 71.6, 33.9, 32.6, 29.4, 25.3; IR (KBr)
ν
max 3300, 2965, 1681, 1500, 1391, 1233, 1199, 1079, 1025, 763
5a-Methyl-5,6,7,8,9,11-hexahydro-5aH-pyrido[2,1-b]quinazolin-
9-one (5g). Yellow solid; mp = 156-158 °C; Rf = 0.50 (hexane/
EtOAc = 30/70); 1H NMR (500 MHz, CDCl3) δ 6.95-6.92 (m,
2H), 6.69-6.66 (m, 1H), 6.47 (d, J = 7.4 Hz, 1H), 4.22 (ABq,
J = 17.5 Hz, 2H), 3.80 (brs, 1H), 2.44-2.26 (m, 2H), 1.98-1.88
(m, 3H), 1.78-1.67 (m, 1H), 1.47 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 169.0, 141.0, 128.4, 127.4, 126.8, 119.3, 116.1, 68.3,
39.7, 37.3, 32.9, 26.8, 16.8; IR (KBr) νmax 3293, 2941, 2862, 1619,
1491, 1271, 1113, 749, 541 cm-1; HRMS calcd for C13H17N2O
(Mþ þ H) 217.1341, found 217.1346.
cm-1; HRMS calcd for C12H14FN2O (Mþ þ H) 221.1090, found
221.1097.
11,11a-Dimethyl-1,3,4,6,11,11a-hexahydro[1,4]oxazino[3,4-b]-
quinazolin-4-one (5n). Brown solid; mp = 192-194 °C; Rf =
0.32 (DCM/MeOH = 95/05); 1H NMR (300 MHz, CDCl3)
δ 7.13 (t, J = 7.6 Hz, 1H), 7.04 (d, J = 7.4 Hz, 1H), 6.80 (t, J =
7.4 Hz, 1H), 6.71 (d, J = 8.1 Hz, 1H), 4.70 (ABq, J = 16.8 Hz,
2H), 4.12 (ABq, J = 4.1 Hz, 2H), 3.92 (ABq, J = 11.7 Hz, 2H),
2.82 (s, 3H), 1.45 (s, 3H) ; 13C NMR (75 MHz, CDCl3) δ 165.2,
144.1, 128.0, 126.3, 121.2, 119.5, 114.5, 72.2, 68.0, 39.3, 33.0,
29.8, 19.8; IR (KBr) νmax 2923, 1670, 1605, 1494, 1458, 1397,
1296, 1110, 1067, 981, 837, 600 cm-1; HRMS calcd for
C13H17N2O2 (Mþ þ H) 233.1290, found 233.1296.
3a,8-Dimethyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]quinazolin-
1-one (5h). Brown solid; mp = 156-158 °C; Rf = 0.53 (hexane/
EtOAc = 30/70); 1H NMR (300 MHz, CDCl3) δ 6.91 (t, J = 8.3
Hz, 1H), 6.59 (d, J = 7.6 Hz, 1H), 6.36 (d, J = 8.3 Hz, 1H), 4.45
(ABq, J = 16.6 Hz, 2H), 3.75 (brs, 1H), 2.54-2.46 (m, 2H), 2.23
(s, 3H), 2.11-2.02 (m, 2H), 1.54 (s, 3H); 13C NMR (75 MHz,
CDCl3) δ 174.1, 141.7, 135.7, 127.2, 120.8, 115.9, 114.1, 71.4,
37.4, 32.7, 29.5, 25.2, 18.5; IR (KBr) νmax 3319, 2969, 2923, 1675,
1236, 1200, 1099, 778, 673 cm-1; HRMS calcd for C13H17N2O
(Mþ þ H) 217.1340, found 217.1347.
(2R,3aR)-3a-Methyl-2-phenyl-1,2,3,3a,4,9-hexahydropyrrolo-
[2,1-b]quinazolin-1-one (5p). Pale yellow solid; mp = 170-172 °C;
Rf = 0.46 (hexane/EtOAc = 30/70); 1H NMR (500 MHz,
CDCl3) δ 7.37-7.18 (m, 5H), 7.02-6.97 (m, 2H), 6.74 (t, J =
7.6 Hz, 1H), 6.49 (d, J = 8.1 Hz, 1H), 4.40 (ABq, J = 16.8 Hz,
2H), 3.84 (t, J = 9.6 Hz, 1H), 3.82 (brs, 1H), 2.53 (dd, J =
13.0, 9.6 Hz, 1H), 2.12 (dd, J = 13.0, 9.6 Hz, 1H), 1.62 (s, 3H);
13C NMR (75 MHz, CDCl3) δ 174.9, 141.9, 139.1, 128.8,
128.1, 127.5, 127.1, 126.8, 119.2, 117.5, 116.4, 70.0, 47.1,
42.7, 39.0, 25.8; IR (KBr) νmax 3303, 2974, 1680, 1489, 1228,
1119, 1076, 751, 696 cm-1; HRMS calcd for C18H19N2O
(Mþ þ H) 279.1497, found 279.1508.
3a,5,7-Trimethyl-1,2,3,3a,4,9-hexahydropyrrolo[2,1-b]quina-
zolin-1-one (5i). Pale yellow solid; mp = 136-138 °C; Rf = 0.37
(hexane/EtOAc = 30/70); 1H NMR (300 MHz, CDCl3) δ 6.71
(s, 1H), 6.68 (s, 1H), 4.46 (ABq, J = 16.8 Hz, 2H), 3.39 (brs, 1H),
2.59-2.39 (m, 2H), 2.20 (s, 3H), 2.15-2.09 (m, 2H), 2.05 (s, 3H),
1.50 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 173.8, 137.3, 129.4,
128.0, 124.8, 123.7, 116.9, 71.9, 38.6, 33.2, 29.5, 25.7, 20.4, 16.9;
(2S,3aR)-3a-Methyl-2-phenyl-1,2,3,3a,4,9-hexahydropyrrolo-
[2,1-b]quinazolin-1-one (5p0). Yellow solid; mp = 122-124 °C;
5974 J. Org. Chem. Vol. 75, No. 17, 2010